18 Dec 2025 Confo Therapeutics Nominates SSTR5 Agonist Antibody CFTX-2034 as Development Candidate for Post-Bariatric Hypoglycemia Multiple categories
16 Dec 2025 ATMP XB strengthens the Flemish-Dutch innovation ecosystem for cell and gene therapy with a €3.5 million investment Multiple categories
13 Nov 2025 Tebubio Partners with 4Dcell to Expand Access to Advanced 3D Cell Culture, “NAMs”, Technologies Member news
12 Nov 2025 Tebubio and Apricell Announce Partnership to Advance 3D Cell Culture and Organoid Research Member news
07 Nov 2025 Merck KGaA expands collaboration with ONTOFORCE to accelerate data-driven discovery Multiple categories
21 Oct 2025 KU Leuven study uncovers how breast cancer cells pause to survive chemotherapy — and how to target them Multiple categories
20 Oct 2025 Belgian neurotech startup Farow raises €1.6M to expand its AI platform for epilepsy and Parkinson’s disease Multiple categories
08 Oct 2025 Confo Therapeutics awarded VLAIO grant for development of ultra-long-acting antibody-based GPCR therapeutics in endocrine and metabolic conditions Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
